Rifabutin accumulates in the lens and reduces retinal function in the rabbit eye

Retina

Volumn 29, Issue 1, 2009, Pages 106-111

  Myers, Anna Cardiakidis ^a   Kjellström, Sten ^a   Bruun, Anitha ^a   Isaksson, Björn ^a   Ghosh, Fredrik ^a   AndrIasson, Sten ^a   Ponjavic, Vesna ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; PEANUT AGGLUTININ; PROTEIN KINASE C; RIFABUTIN; VIMENTIN; ANTIINFECTIVE AGENT;

ANIMAL TISSUE; ARTICLE; B WAVE; CLINICAL ASSESSMENT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORNEA; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; ELECTRORETINOGRAM; EYE; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LENS; MALE; MORPHOLOGY; NONHUMAN; RABBIT; RECORDING; RETINA; RETINA CONE; RETINA ROD; VISION; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ELECTRORETINOGRAPHY; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RETINA DISEASE;

ANIMALS; ANTI-BACTERIAL AGENTS; ELECTRORETINOGRAPHY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLIAL FIBRILLARY ACIDIC PROTEIN; LENS, CRYSTALLINE; MALE; PROTEIN KINASE C; RABBITS; RETINA; RETINAL DISEASES; RIFABUTIN; VIMENTIN;

EID: 61549105919     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e318180ab3c     Document Type: Article

References (27)

1. Soukasian SK, Raizman MB. Ocular toxicity of systemic medications. In: Albert DM, Jacobiec FA, eds. Principles and Practice of Ophthalmology. Chapter 42. Philadelphia, PA: W.B. Saunders Company; 2000:455-468.
2. Fraunfelder FT, Meyer SM. Drug-Induced Ocular Side Effects and Their Drug Interactions. 3rd ed. Philadelphia, PA: Lea & Febiger; 1989.
3. Brogden RN, Fitton A. Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1994;47:983-1009.
4. Jacobs DS, Piliero PJ, Kuperwaser MG, et al. Acute uveitis associated with rifabutin use in patients with human immunodeficiency virus infection. Am J Ophthalmol 1994;118:716- 722.
5. Saran BR, Maguire AM, Nichols C, et al. Hypopion uveitis in patient with acquired immunodeficiency syndrome treated for systemic Mycobacterium avium complex infection with rifabu-tin. Arch Ophthalmol 1994;112:1159-1165.
6. Becker K, Schimkat M, Jablonowski H, et al. Anterior uveitis associated with rifabutin medication in AIDS patients. Infection 1996;24:34-36.
7. Arevalo JF, Russack V, Freeman WR. New ophthalmic manifestations of presumed rifabutin-related uveitis. Ophthalmic Surg Lasers 1997;28:321-324.
8. Fraunfelder FW, Rosembaum JT. Drug-induced uveitis. Incidence, prevention and treatment. Drug Saf 1997;17:197-207.
9. Fineman MS, Vander J, Regillo CD, et al. Hypopion uveitis in immunocompetent patients treated for Mycobacterium avium complex pulmonary infection with rifabutin. Retina 2001;21: 531-533.
10. Khan MA, Singh J, Dhillon B. Rifabutin-induced uveitis with inflammatory vitreous infiltrate. Eye 2000;14:344-346.
11. Chaknis MJ, Brooks SE, Mitchell KT, et al. Inflammatory opacities of the vitreous in rifabutin-associated uveitis. Am J Ophthalmol 1996;122:580 -582.
12. Skolik S, Willermain F, Caspers LE. Rifabutin associated panuveitis with retinal vasculitis in pulmonary tuberculosis. Ocul Immunol Inflamm 2005;13:483-485.
13. Coutinho AB, Cheema D, Pereira PR, et al. Corneal endothe-lial deposits associated with rifabutin use. J Ocul Pharmacol Ther 2005;21:166-169.
14. Smith JA, Mueller BU, Nussenblatt RB, et al. Corneal endo-thelial deposits in children positive for human immunodeficiency virus receiving rifabutin prophylaxis for Mycobacte-rium avium complex bacteremia. Am J Ophthalmol 1999;127: 164-169.
15. Holland SP, Chang CW, Vagh M, et al. Corneal endothelial deposits in patients with HIV infection or AIDS: epidemio-logic evidence of the contribution of rifabutin. Can J Ophthal-mol 1999;34:204 -209.
16. Chu DS, Zaidman GW, Meisler DM, et al. Human immunodeficiency virus-positive patients with posterior intracorneal precipitates. Ophthalmology 2001;108:1853-1857.
17. Ponjavic V, Gränse L, Bengtsson Stigmar E, et al. Retinal dysfunction and anterior segment deposits in a patient treated with rifabutin. Acta Ophthalmol Scand 2002;80:553-556.
18. Brughera M, Scampini G, Newman AJ, et al. Overview of toxicological data on rifabutin. Exp Toxic Pathol 1995;47:1-9.
19. Haslam JL, Egodage KL, Chen Y, et al. Stability of rifabutin in two extemporaneously compounded oral liquids. Am J Health-Syst Pharm 1999;56:333-336.
20. Gjörloff K, Andréasson S, Ehinger B. Standardized full-field electroretinography in rabbits. Doc Ophthalmol 2004; 109:163-168.
21. Marmor MF, Holder GE, Seelinger MW, et al. International Society for Clinical Electrophysiology of Vision. Standard for clinical electroretinography (2004 update). Doc Ophthalmol 2004;108:107-114.
22. Blanks J, Johnson LV. Specific binding of peanut lectin to a class of retinal photoreceptor cells. Invest Ophthalmol Vis Sci 1982;25:546-557.
23. Koistinaho J, Sagar SM. Localization of protein kinase C subspecies in the rabbit retina. Neurosci Lett 1994;177:15-18.
24. Ghosh F, Görloff K. Protein kinase C expression in the rabbit retina after laser photocoagulation. Graefe's Arch Clin Exp Ophthalmol 2005;243:803-804.
25. Wood JPM, McCord RJ, Osborne NN. Retinal protein kinase C. Neurochem Int 1997;30:119-136.
26. Lewis P, Fisher SK. Up-regulation of glial fibrillary acidic protein in response to retinal injury: its potentional role in glial remodeling and a comparison to vimentin expression. Int Rev Cytol 2003;230:263-289.
27. Maehara S, Itoh N, Wakaiki S, et al. The effects of cataract stage, lens-induced uveitis and cataract removal on ERG in dogs with cataract. Veterinary Opthalmol 2007;10:5:308-312.